Performance Comparison Between Fanfilcon A and Senofilcon A Sphere Lenses
1 other identifier
interventional
64
1 country
4
Brief Summary
Prospective, multi-center, bilateral, double-masked, randomized, cross-over, daily wear, 1 month dispensing study (2 weeks each lens pair)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2016
Shorter than P25 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 27, 2016
CompletedFirst Submitted
Initial submission to the registry
November 3, 2016
CompletedFirst Posted
Study publicly available on registry
November 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2016
CompletedResults Posted
Study results publicly available
December 8, 2017
CompletedApril 2, 2018
March 1, 2018
2 months
November 3, 2016
November 10, 2017
March 6, 2018
Conditions
Outcome Measures
Primary Outcomes (11)
Overall Comfort
Subjective assessment for comfort is assessed. Scale 0-10, 0=painful, 10=can't feel
2 weeks
Overall Dryness
Subjective ratings for dryness is assessed on a scale of 0-10, 0=extremely dry, 10=no dryness
2 weeks
Vision Quality
Subjective ratings of vision quality is assessed on a scale 0-10, 0=not sharp/not clear, 10=sharp/clear
2 weeks
Lens Handling
Subjective ratings of lens handling - insertion and removal - is assessed using scale 0-10, 0=difficult to handle, 10=very easy to handle
2 weeks
Vision Satisfaction
Subjective ratings of vision satisfaction is assessed on a scale 0-10, 0=completely dissatisfied, 10=completely satisfied.
2 weeks
Lens Centration
Lens centration will be recorded by degree and direction in the primary position. (Optimum, decentration acceptable, decentration unacceptable).
2 weeks
Conjunctival Staining
Assessed using slit lamp with blue light and sodium fluorescein, low medium magnification. 0=None, no staining present 1. Very slight 2. Slight 3. Moderate 4. Severe
2 weeks
Smoothness
Subjective ratings for lens sensation of smoothness is assessed on a scale 0-10, 0=not smooth at all, 10=totally smooth
2 weeks
Clean Feeling
Subjective ratings for lens clean feeling is assessed on a scale 0-10, 0=not clean at all, 10=lenses feel perfectly clean
2 weeks
Lens Hydrated
Subjective ratings for lens sensation is assessed on a scale 0-10, 0=totally dehydrated, 10=totally hydrated
2 weeks
Lens Wettability
Subjective ratings for lens wettability is assessed on a scale 0-10, 0=non-wettable, 10=highly wettable
2 weeks
Study Arms (2)
fanfilcon A
ACTIVE COMPARATORParticipants are randomized to wear fanfilcon A for two weeks during the cross over study.
senofilcon A
ACTIVE COMPARATORParticipants are randomized to wear senofilcon A for two weeks during the cross over study.
Interventions
Eligibility Criteria
You may qualify if:
- Is between 18 and 40 years of age (inclusive)
- Has read, understood and signed the information consent letter
- Has had a self-reported eye exam in the last two years
- Is a spherical soft contact lens wearer
- Has a contact lens prescription that fits within the available parameters of the study lenses
- Has a spectacle cylinder no greater than 0.75D (Diopters) in each eye
- Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye
- Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses
- Has clear corneas and no active ocular disease
- Is willing and anticipated to be able to comply with the wear schedule (8 hours per day; 5 days a week of lens wear)
- Is willing and able to follow instructions and maintain the appointment schedule
You may not qualify if:
- A person will be excluded from the study if he/she:
- Has a history of not achieving comfortable CL (Contact Lens) wear (defined as 5 days per week; \>8 hours/day)
- Is currently wearing senofilcon C (2 weeks lens), senofilcon A 1-Day, senofilcon C (monthly lens) or enfilcon A contact lenses
- Is habitually using rewetting/ lubricating eye drops more than once per day
- Presents with clinically significant anterior segment abnormalities
- Presents with ocular or systemic disease or need of medications which might interfere with contact lens wear
- Presents with slit lamp findings that would contraindicate contact lens wear such as:
- Pathological dry eye or associated findings
- Significant pterygium, pinguecula, or corneal scars within the visual axis
- Neovascularization \> 0.75 mm in from of the limbus
- Giant papillary conjunctivitis (GCP) worse than grade 1
- Anterior uveitis or iritis (or history in past year)
- Seborrheic eczema of eyelid region, Seborrheic conjunctivitis
- History of corneal ulcers or fungal infections
- Poor personal hygiene
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Eric M. White O. D., Inc
San Diego, California, 92123, United States
Golden Vision
Sarasota, Florida, 34232, United States
Kannarr Eye Care
Pittsburg, Kansas, 66762, United States
Nittany Eye Associates
State College, Pennsylvania, 16801, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jose Vega, O.D., MSc., FAAO
- Organization
- CooperVision
Study Officials
- STUDY DIRECTOR
Lyndon Jones, PhD, FAAO
Centre for Contact Lens Research
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2016
First Posted
November 7, 2016
Study Start
October 27, 2016
Primary Completion
December 14, 2016
Study Completion
December 14, 2016
Last Updated
April 2, 2018
Results First Posted
December 8, 2017
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share